CENTOGENElogo.jpg
CENTOGENE Extends Global Parkinson’s Disease Study
10 mai 2021 06h30 HE | CENTOGENE GmbH
Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD) The Rostock International Parkinson's Disease (ROPAD) Study aims to...